These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 4639306)

  • 1. Studies on morphinan derivatives. I. The synthesis of several new 3-substituted derivatives of N-methylmorphinan having antitussive activities.
    Murakami M; Inukai N; Nagano N
    Chem Pharm Bull (Tokyo); 1972 Aug; 20(8):1699-705. PubMed ID: 4639306
    [No Abstract]   [Full Text] [Related]  

  • 2. Studies on morphinan derivatives. II. The synthesis of d-3-methyl-N-methylmorphinan, a new antitussive.
    Murakami M; Kawahara S; Inukai N; Nagano N; Iwamoto H
    Chem Pharm Bull (Tokyo); 1972 Aug; 20(8):1706-10. PubMed ID: 4639307
    [No Abstract]   [Full Text] [Related]  

  • 3. Antitussive activity and other related pharmacological properties of d-3-methyl-N-methylmorphinan (AT-17).
    Kasé Y; Kito G; Miyata T; Uno T; Takahama K; Ida H
    Arzneimittelforschung; 1976; 26(3):353-60. PubMed ID: 989326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and some properties of two salsalate derivatives.
    Galzigna L; Licit L; De Pieri GF; Bonora GM; Signor A
    Farmaco; 1993 Jan; 48(1):95-103. PubMed ID: 8457280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural requirement for antitussive activity in some novel 16-substituted derivatives of 6,14-endoethenotetrahydrothebaine.
    Boura AL; Haddlesey DI; Harry EJ; Lewis JW; Mayor PA
    J Pharm Pharmacol; 1968 Dec; 20(12):961-3. PubMed ID: 4388343
    [No Abstract]   [Full Text] [Related]  

  • 6. [Pharmacological studies of a new potent antitussive agent, 14-hydroxy-dihydro-6 beta-thebainol-4-methyl ether (oxymethebanol)].
    Takagi H; Kobayashi S; Kumakura S; Mori M; Koike H
    Nihon Yakurigaku Zasshi; 1969 Mar; 65(2):120-45. PubMed ID: 4390383
    [No Abstract]   [Full Text] [Related]  

  • 7. Circulatory, respiratory and antitussive effects of azidomorphine and related substances.
    Knoll J; Makleit S; Friedmann T; Hársing LG; Hadházy P
    Arch Int Pharmacodyn Ther; 1974 Aug; 210(2):241-9. PubMed ID: 4441191
    [No Abstract]   [Full Text] [Related]  

  • 8. Pharmacological studies on a new specifically potent antitussive agent, 14-hydroxydihydro-6 beta-thebainol-4-methylether (oxymethebanol).
    Kobayashi S; Hasegawa K; Mori M; Takagi H
    Arzneimittelforschung; 1970 Jan; 20(1):43-6. PubMed ID: 5467447
    [No Abstract]   [Full Text] [Related]  

  • 9. Synthetic 14-hydroxymorphinan narcotic antagonists.
    Pachter IJ
    Adv Biochem Psychopharmacol; 1973; 8(0):57-62. PubMed ID: 4153098
    [No Abstract]   [Full Text] [Related]  

  • 10. Triphenylpropylpiperazine derivatives as new potent analgetic substances.
    Regnier GL; Canevari RJ; Le Douarec JC; Holstorp S; Daussy J
    J Med Chem; 1972 Mar; 15(3):295-301. PubMed ID: 5059214
    [No Abstract]   [Full Text] [Related]  

  • 11. 3,5-Propanopiperidine derivatives as potential analgesics.
    Oki E; Oida S; Ohashi Y; Yoshida A; Kamoshita T
    Chem Pharm Bull (Tokyo); 1974 May; 22(5):1014-21. PubMed ID: 4425529
    [No Abstract]   [Full Text] [Related]  

  • 12. On the sites of antitussive action of d-3-methyl-N-methylmorphinan (AT-17).
    Kasé Y; Kito G; Miyata T; Takahama K; Uno T
    Arzneimittelforschung; 1976; 26(3):361-6. PubMed ID: 989327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-antitussive activity relationships of naltrindole derivatives. Identification of novel and potent antitussive agents.
    Sakami S; Maeda M; Kawai K; Aoki T; Kawamura K; Fujii H; Hasebe K; Nakajima M; Endo T; Ueno S; Ito T; Kamei J; Nagase H
    J Med Chem; 2008 Aug; 51(15):4404-11. PubMed ID: 18637671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-acyl-2-substituted-1,3-thiazolidines, a new class of non-narcotic antitussive agents: studies leading to the discovery of ethyl 2-[(2-methoxyphenoxy)methyl]-beta-oxothiazolidine-3-propanoate.
    Gandolfi CA; Di Domenico R; Spinelli S; Gallico L; Fiocchi L; Lotto A; Menta E; Borghi A; Dalla Rosa C; Tognella S
    J Med Chem; 1995 Feb; 38(3):508-25. PubMed ID: 7853344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dextromethorphan-monoamine oxidase inhibitor interaction in rabbits.
    Sinclair JG
    J Pharm Pharmacol; 1973 Oct; 25(10):803-8. PubMed ID: 4149741
    [No Abstract]   [Full Text] [Related]  

  • 16. Binding of dimemorfan to sigma-1 receptor and its anticonvulsant and locomotor effects in mice, compared with dextromethorphan and dextrorphan.
    Chou YC; Liao JF; Chang WY; Lin MF; Chen CF
    Brain Res; 1999 Mar; 821(2):516-9. PubMed ID: 10064839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacology of ethyl dibunate, a new antitussive agent.
    Shemano I; Beiler JM; Hitchens JT
    Arch Int Pharmacodyn Ther; 1967 Feb; 165(2):410-24. PubMed ID: 6031473
    [No Abstract]   [Full Text] [Related]  

  • 18. The animal pharmacology of buprenorphine, an oripavine analgesic agent.
    Cowan A; Doxey JC; Harry EJ
    Br J Pharmacol; 1977 Aug; 60(4):547-54. PubMed ID: 409449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved synthesis and additional pharmacology of the potent analgetic (-)-5-m-hydroxyphenyl-2-methylmorphan.
    Rogers ME; May EL
    J Med Chem; 1974 Dec; 17(12):1328-30. PubMed ID: 4473552
    [No Abstract]   [Full Text] [Related]  

  • 20. Synthesis of B-C trans-fused morphine structures V. Pharmacological summary of trans-morphine derivatives and an improved synthesis of trans-codeine.
    Kugita H; Takeda M; Inoue H
    J Med Chem; 1970 Sep; 13(5):973-5. PubMed ID: 5458394
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.